Generali Asset Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Sell
48,427
-1,253
-3% -$46.5K 0.03% 303
2026
Q1
$1.73M Sell
49,680
-135
-0.3% -$6.39K 0.04% 319
2025
Q4
$1.94M Sell
49,815
-19,065
-28% -$882K 0.04% 305
2025
Q3
$2.6M Buy
68,880
+34,912
+103% +$1.67M 0.06% 254
2025
Q2
$1.39M Sell
33,968
-33,290
-49% -$1.45M 0.03% 382
2025
Q1
$2.47M Buy
67,258
+35,194
+110% +$1.48M 0.06% 277
2024
Q4
$1.42M Buy
+32,064
New +$1.44M 0.04% 339

Other funds holding QGEN

Generali Asset Management's QGEN Position: Q2 2026 in Review

Generali Asset Management reduced its Qiagen (QGEN) stake by 2.5% in Q2 2026, selling an estimated $46.5K and leaving 48,427 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #303.

Generali Asset Management first reported a position in QGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.6M in Q3 2025. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Generali Asset Management held 48,427 shares of Qiagen worth $1.64M as of Q2 2026.
  • Generali Asset Management sold 1,253 Qiagen shares in Q2 2026, an estimated $46.5K.
  • Qiagen made up 0.03% of Generali Asset Management's portfolio in Q2 2026, its #303 holding.
  • Generali Asset Management first reported a position in Qiagen in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Qiagen position peaked at $2.6M in Q3 2025.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.